We are live on
!
Find out more
Vera Therapeutics
VERA
VERA
214 hedge funds and large institutions have $3.75B invested in Vera Therapeutics in 2025 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 79 increasing their positions, 59 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
290% more call options, than puts
Call options by funds: $48.6M | Put options by funds: $12.5M
244% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 18
98% more capital invested
Capital invested by funds: $1.89B → $3.75B (+$1.86B)
34% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 59
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
22% more funds holding
Funds holding: 175 → 214 (+39)
13.82% more ownership
Funds ownership: 101.95% → 115.77% (+14%)
Holders
214
Holders Change
+39
Holders Change %
+22.29%
% of All Funds
2.6%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.11%
New
62
Increased
79
Reduced
59
Closed
18
Calls
$48.6M
Puts
$12.5M
Net Calls
+$36.2M
Net Calls Change
+$38.6M
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$100M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$63.8M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$60.3M |
| 4 |
Holocene Advisors
New York
|
+$46.4M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$41.4M |
